See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
MFA Financial, Inc. (MFA) - free report >>
PBF Energy Inc. (PBF) - free report >>
Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MFA Financial, Inc. (MFA) - free report >>
PBF Energy Inc. (PBF) - free report >>
Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 11th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
PBF Energy Inc. (PBF - Free Report) : This company that engages in refining and supplying petroleum products has seen the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.
PBF Energy Inc. Price and Consensus
PBF Energy Inc. price-consensus-chart | PBF Energy Inc. Quote
Praxis Precision Medicines, Inc. (PRAX - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 15% over the last 60 days.
Praxis Precision Medicines, Inc. Price and Consensus
Praxis Precision Medicines, Inc. price-consensus-chart | Praxis Precision Medicines, Inc. Quote
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
MFA Financial, Inc. (MFA - Free Report) : This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
MFA Financial, Inc. Price and Consensus
MFA Financial, Inc. price-consensus-chart | MFA Financial, Inc. Quote
Griffon Corporation (GFF - Free Report) : This diversified management and holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Griffon Corporation Price and Consensus
Griffon Corporation price-consensus-chart | Griffon Corporation Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.